AGN vs NSB

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

AGN

ARGENICA FPO [AGN]

54MEDIUM

NSB

NEUROSCIEN FPO [NSB]

54MEDIUM

Score Breakdown

AGN NSB
Technical
39
42
Catalyst
51
51
Sentiment
50
50
Fundamental
66
72
Momentum
42
36
Risk Gate
42
50

Key Metrics

AGN Metric NSB
$23.8MMarket Cap$24.9M
74KAvg Volume (20d)260K
N/AShort InterestN/A
$0.38052-Week High$0.190
$0.08752-Week Low$0.055
-7.7%Daily Change-6.2%
$0.180Reference Price$0.061
-20.8%ROE-29.7%
-24.9%Profit MarginN/A

Active Signals

AGN Signals

●MACD momentum is losing steam
●Above-average volume (1.9x) on a red day — sellers in control
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Drifting lower — down 10.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)
●4C filed 2026-07-23
●Low P/S ratio (4.3x)

NSB Signals

●Above-average volume (1.9x) on a red day — sellers in control
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (7 quarters)
●4C filed 2026-07-28
●Very high P/S ratio (61.9x)
●Strong revenue growth (+88%)

Ask Scout AI to compare AGN and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AGN vs EPI →CMP vs PHX →CMP vs NSB →CMP vs EPI →PHX vs PIQ →
AGN Full Analysis → NSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).